Progesterone for Ox: Reproductive Uses, CIDR Protocols & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Progesterone used in cattle is a reproductive hormone most commonly delivered as an intravaginal insert called a CIDR. In the US, the best-known product is EAZI-BREED CIDR, which contains 1.38 g of progesterone in a silicone insert placed in the vagina for a set number of days under your vet's direction. The goal is to temporarily mimic the luteal phase, then allow a controlled drop in progesterone when the insert is removed so estrus and ovulation can be timed more predictably.

In practical herd medicine, progesterone is not usually a stand-alone fertility drug. It is part of a planned breeding protocol that may also include prostaglandin F2alpha and sometimes GnRH. Merck notes that CIDR devices are labeled for estrus synchronization in beef and dairy cattle, and FDA regulations describe a 7-day intravaginal use pattern for approved indications.

This medication is used in food animals, so label directions, handling precautions, and breeding goals matter. Your vet will choose whether progesterone fits a natural-service program, heat-detection program, fixed-time AI protocol, or a more customized reproductive plan based on age, cycling status, days postpartum, body condition, and herd logistics.

In cattle, progesterone is used mainly to control or synchronize estrous cycles. FDA-approved uses for the cattle insert include synchronization of estrus in lactating dairy cows, suckled beef cows, and replacement beef and dairy heifers. It is also labeled for induction of estrous cycles in anestrous lactating dairy cows, advancement of first postpartum estrus in suckled beef cows, and advancement of first pubertal estrus in replacement beef heifers.

A common label protocol is a 7-day CIDR program. The insert is placed for 7 days, and 25 mg dinoprost IM is given 1 day before removal. After removal, cattle are watched for heat and bred about 12 hours after estrus begins. Merck also describes CIDR-based programs paired with GnRH at insertion and PGF2alpha at removal, with insemination often planned 48 to 72 hours later, sometimes with another GnRH dose depending on the protocol.

Your vet may recommend progesterone when heat detection has been inconsistent, when postpartum cows are slow to resume cycling, when heifers need a tighter breeding window, or when embryo transfer or timed AI scheduling is part of the herd plan. It is not a fertility guarantee. Good nutrition, adequate postpartum recovery time, body condition, and overall reproductive health still strongly affect results.

Progesterone dosing in cattle is protocol-based, not weight-based in the way many other medications are. For the FDA-approved cattle insert, the labeled dose is one EAZI-BREED CIDR insert per animal for 7 days. For several approved synchronization uses, the label also directs dinoprost 25 mg IM on Day 6, which is 1 day before CIDR removal.

Another widely used veterinary approach is a 7-day CO-Synch + CIDR-style protocol, where your vet may give GnRH at CIDR insertion, remove the insert on Day 7, give PGF2alpha at removal, and plan breeding 48 to 72 hours later with or without a second GnRH dose depending on the exact program. Merck emphasizes that protocol choice should match the class of cattle, postpartum status, facilities, labor, semen type, and whether estrus detection is practical.

Do not improvise timing. A one-day error can reduce synchronization success. The insert should be placed with the correct applicator, handled with gloves, and removed on schedule. If an insert is lost early, contaminated, or retained longer than intended, contact your vet before continuing the breeding plan.

Because this is a food-animal drug, follow your vet's instructions exactly. When used according to the cattle label, the product has no required pre-slaughter withdrawal interval and no milk discard time. Extra-label use in food animals has legal limits, and your vet should direct any non-label decisions.

Most cattle tolerate CIDR-based progesterone protocols well, but mild local irritation can happen. The product information notes that some animals develop a clear, cloudy, or bloody vaginal discharge at removal. This is generally linked to local irritation from the insert and does not usually reduce conception rates when the protocol is otherwise followed correctly.

Other practical concerns include insert loss, contamination during placement, or difficulty removing the device. If your ox or cow shows marked straining, foul-smelling discharge, fever, obvious pain, or signs of systemic illness, contact your vet promptly. Those findings are not typical and may suggest vaginitis, trauma, or another reproductive problem that needs an exam.

Human safety matters too. The label advises wearing protective gloves when handling inserts. Progesterone products can be absorbed through skin contact, so pregnant people and anyone trying to avoid hormone exposure should be especially cautious and let trained farm staff or veterinary personnel handle insertion and removal.

If the animal could already be pregnant, your vet should confirm status before using a synchronization protocol. Reproductive hormones used at the wrong time can disrupt pregnancy management and complicate herd records.

Progesterone in cattle is usually combined intentionally with other reproductive drugs rather than avoided with them. The most common planned combinations are dinoprost or another prostaglandin product and GnRH products such as gonadorelin, because these drugs act on different parts of the estrous cycle. In other words, these are usually protocol partners, not accidental interactions.

The bigger concern is using the wrong drug at the wrong stage of the cycle. For example, prostaglandin products can cause luteolysis and are used to help bring animals into heat, but they are also associated with abortion risk in pregnant cattle. That is why pregnancy status, postpartum interval, and breeding records should be reviewed before starting a CIDR program.

There is limited value in stacking extra hormones or changing timing without veterinary oversight. Mixing protocols, reusing inserts outside label directions, or adding unplanned reproductive drugs can reduce synchronization success and make breeding dates harder to interpret.

You can also ask your vet about interactions with herd-level management factors that act like "non-drug interactions," including poor body condition, stress, suckling status, postpartum disease, and inadequate heat detection. In cattle reproduction, those factors often affect outcomes as much as the medication plan itself.